ADMETatlas — Peptide ADMET Evidence Atlas

Evidence entries

129records·53peptides

Showing reference-linked Volume of distribution evidence with reported value, assay context, interpretation role, and reference access kept separate.

Assay context

Evidence role

All129 Curated comparable122 Reported7

#	Endpoint	Peptide		Assay context	Evidence role	Reference
1	Volume of distribution Distribution / Barrier	ATLPC0011879	22 L	Canadian Product Monograph 10.3 pharmacokinetics manual extractionplasmahuman	Comparable	Open
2	Volume of distribution Distribution / Barrier	ATLPC0021413	0.3 L/kg	Canadian Product Monograph Table single-dose pharmacokinetics manual extractionserumhumanintravenoussingle dose25 mcg intravenous nafarelin; Vd beta	Comparable	Open
3	Volume of distribution Distribution / Barrier	ATLPC0027686	16.1 L	UK eMC SmPC section 5.2 pharmacokinetics manual extractionserumhumanintravenoussteady statehealthy volunteers after intravenous administration	Comparable	Open
4	Volume of distribution Distribution / Barrier	ATLPC0001542	0.15-0.3 L/kg	Australian Medicine Finder PI 5.2 pharmacokinetics manual extractionplasmahuman	Comparable	Open
5	Volume of distribution Distribution / Barrier	ATLPC0009237	28.3 L	THPdb curated therapeutic product PK entry	Comparable	Open
6	Volume of distribution Distribution / Barrier	ATLPC0009758	0.12 L/kg	THPdb curated therapeutic product PK entrySubcutaneous	Comparable	Open
7	Volume of distribution Distribution / Barrier	ATLPC0009758	0.12 L/kg	THPdb curated therapeutic product PK entry	Comparable	Open
8	Volume of distribution Distribution / Barrier	ATLPC0024280	0.07 L/kg	THPdb curated therapeutic product PK entrySubcutaneous	Comparable	Open
9	Volume of distribution Distribution / Barrier	ATLPC0024280	0.07 L/kg	THPdb curated therapeutic product PK entry	Comparable	Open
10	Volume of distribution Distribution / Barrier	ATLPC0010824	103 mL/kg	THPdb curated therapeutic product PK entrySubcutaneous	Comparable	Open
11	Volume of distribution Distribution / Barrier	ATLPC0010824	103 mL/kg	THPdb curated therapeutic product PK entry	Comparable	Open
12	Volume of distribution Distribution / Barrier	ATLPC0015133	19.2 L	THPdb curated therapeutic product PK entry	Comparable	Open
13	Volume of distribution Distribution / Barrier	ATLPC0015133	19.2 L	THPdb curated therapeutic product PK entrySubcutaneous	Comparable	Open
14	Volume of distribution Distribution / Barrier	ATLPC0001542	range 0.15-0.3 L/kg	curated therapeutic product PK entryOfficial label support for calcitonin salmon apparent volume of distribution.	Comparable	Open
15	Volume of distribution Distribution / Barrier	ATLPC0002714	0.25 L/kg	curated therapeutic product PK entryOfficial label support for glucagon mean volume of distribution.	Comparable	Open
16	Volume of distribution Distribution / Barrier	ATLPC0011948	0.102 L/kg	Apparent volume of distribution in Gottingen mini pig at 2 nmol/kg, ivporcineiv	Comparable	Open
17	Volume of distribution Distribution / Barrier	ATLPC0024280	0.067 L/kg	Apparent volume of distribution in Gottingen mini pig at 0.5 nmol/kg, ivporcineiv	Comparable	Open
18	Volume of distribution Distribution / Barrier	ATLPC0006962	0.44 L/kg	Volume of distribution in rat at 4 mg/kg, iv administered as single doserativ	Comparable	Open
19	Volume of distribution Distribution / Barrier	ATLPC0004545	0.17 L/kg	Volume of distribution at steady state in human after iv administrationhumaniv	Comparable	Open
20	Volume of distribution Distribution / Barrier	ATLPC0018293	0.38 L/kg	Volume of distribution at steady state in human after iv administrationhumaniv	Comparable	Open

1–20 / 129

Measurements

Browse by ADMET domain

Evidence entries